Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.

This research aims to reactivate object-oriented databases using intelligent tools to improve performance and accuracy in ...

A recent dual-cohort study has found that Lupus Low Disease Activity State (LLDAS) is an attainable and effective treatment target for people with lupus nephritis (LN, lupus-related kidney disease).